For over 100 years, C. R. Bard, Inc. has been Advancing the Delivery of Healthcare® by creating innovative products and services that meet the needs of healthcare providers and patients. Today, Bard is a leader in products that focus on Disease State Management in three areas: Vascular, Urology, and Oncology. To complement these areas, Bard has a complete line of advanced Surgical Specialty Products and Services.
A division of C. R. Bard Inc., Bard Electrophysiology is a global company focused on the development and delivery of a broad range of devices for the diagnosis and treatment of cardiac arrhythmias.
Bard Electrophysiology offers a full product portfolio which includes advanced RF ablation and mapping catheters, diagnostic catheters, computer-based electrophysiology mapping and recording systems, temporary pacing electrodes, and vascular/cardiac access devices.
Through our rich history of commitment to innovative products, unparalleled support, and a dedication to education worldwide, Bard Electrophysiology continues to be a leader in the field of EP.
|Mar 22, 2016||PRNewswire UK All - Neuromodulation Devices 2016-2026|
|May 21, 2015||Mass Device - Terumo looks to Olympus for GlideWire distribution|
|Jun 30, 2013||Bost.com - Boston Scientific acquired Bard Elecrtrophysiology|
55 Technology Drive
Lowell, Massachusetts 01851